Lonza | LONN - Pre Tax Profit



Lonza reported CHF624M in Pre-Tax Profit for its fiscal semester ending in December of 2024.


Pre Tax Profit Change Date
Akzo Nobel EUR 179M 10M Jun/2025
Alcon AG USD 199M 215M Jun/2025
Almirall EUR 35.8M 37.9M Mar/2025
AstraZeneca USD 3.13B 275M Jun/2025
BASF EUR 1.05B 1.72B Mar/2025
Bayer EUR -426000000 2.26B Jun/2025
Beiersdorf EUR 408.5M 455.5M Jun/2025
Covestro EUR 11M 152M Jun/2025
Demant DKK 1.46B 497M Jun/2025
Fresenius EUR 491M 120M Jun/2025
Fresenius Medical Care EUR 350.55M 99.9M Jun/2025
Geberit CHF 188.3M 10.5M Sep/2024
Genmab DKK 423M 179M Jun/2025
Givaudan CHF 350M 166M Jun/2024
GlaxoSmithKline GBP 1.89B 221M Jun/2025
GN Store Nord DKK 232M 118M Jun/2025
Hikma Pharmaceutical USD 144M 144M Jun/2024
Johnson Matthey GBP 201M 2M Mar/2025
Merck EUR 829M 127M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Philips EUR 337M 28M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025
Sika AG CHF 372.05M 398.25M Jun/2024
Smith & Nephew 469M 70M Jun/2025
Solvay EUR 7M 108M Jun/2025
UCB EUR 1.22B 781M Dec/2024